Literature DB >> 25769401

The kinetics of regeneration of rhodopsin under enzyme-limited availability of 11-cis retinoid.

Trevor D Lamb1, Robert M Corless2, A Demetri Pananos3.   

Abstract

In order to describe the regeneration of rhodopsin and the recovery of visual sensitivity following exposure of the eye to intense bleaching illumination, two models have been proposed, in which there is either a "resistive" or an "enzymatic" limit to the supply of retinoid. A solution has previously been derived for the resistive model, and here we derive an analytical solution for the enzymatic model and we investigate the form of this solution as a function of parameter values. We demonstrate that this enzymatic model provides a good fit to human post-bleach recovery, for four cases: for rhodopsin regeneration in normal subjects; for psychophysical scotopic dark adaptation in normal subjects; for rhodopsin regeneration and scotopic dark adaptation in fundus albipunctatus patients; and for cone pigment regeneration in normal subjects. Finally, we present arguments favouring the enzymatic model as the cellular basis for normal human rod and cone pigment regeneration.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dark adaptation; Differential equation model; Lambert W function; Opsin; Rate limit; Rhodopsin

Mesh:

Substances:

Year:  2015        PMID: 25769401     DOI: 10.1016/j.visres.2015.02.014

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  2 in total

Review 1.  Why rods and cones?

Authors:  T D Lamb
Journal:  Eye (Lond)       Date:  2015-11-13       Impact factor: 3.775

2.  Rhodopsin kinase and arrestin binding control the decay of photoactivated rhodopsin and dark adaptation of mouse rods.

Authors:  Rikard Frederiksen; Soile Nymark; Alexander V Kolesnikov; Justin D Berry; Leopold Adler; Yiannis Koutalos; Vladimir J Kefalov; M Carter Cornwall
Journal:  J Gen Physiol       Date:  2016-07       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.